Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in RemissionA Randomized Clinical Trial

(2010) Dirk Foell   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis

(2009) Yueh-Sheng Chen et al.   ARTHRITIS RESEARCH & THERAPY

Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis

(2008) H B. Hammer et al.   ANNALS OF THE RHEUMATIC DISEASES

Monomeric Calgranulins Measured by SELDI-TOF Mass Spectrometry and Calprotectin Measured by ELISA as Biomarkers in Arthritis

(2008) D. de Seny et al.   CLINICAL CHEMISTRY

Calprotectin (a major leucocyte protein) is associated with the levels of anti‐CCP and rheumatoid factor in a longitudinal study of patients with very early rheumatoid arthritis

(2008) H. B. Hammer et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?

(2008) Josef S Smolen et al.   ARTHRITIS RESEARCH & THERAPY

Recent developments in the immunobiology of rheumatoid arthritis

(2008) Anna K Andersson et al.   ARTHRITIS RESEARCH & THERAPY